Role of nanotechnology in developing new therapies for diseases of the nervous system

Nanomedicine

Volumn 1, Issue 1, 2006, Pages 9-12

  Jain, K K ^a  

^a Jain Pharma Biotech Biotechnology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; DRUG CARRIER; NANOPARTICLE;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; METHODOLOGY; NANOMEDICINE; NANOTECHNOLOGY; NEUROLOGIC DISEASE; PATHOLOGY;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; NERVOUS SYSTEM DISEASES; PHARMACEUTICAL PREPARATIONS;

EID: 34250374657     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/17435889.1.1.9     Document Type: Review

References (8)

1. Jain KK: Nanobiotechnology: Applications, Markets and Companies. Jain PharmaBiotech, Basel, Switzerland, 1-552 (2006).
2. Saleh A, Schroeter M, Jonkmanns C et al.: In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127(Pt 7), 1670-1677 (2004).
3. Llinás RR, Walton KD, Nakao M et al.: Neuro-vascular central nervous recording/stimulating system: using nanotechnology probes. J. Nanopart. Res. 7, 111-127(2005).
4. Silva GA: Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system. Surg. Neurol 63, 301-306 (2005).
5. McKenzie J.L. Waid MC, Shi R. Webster TJ: Decreased (unctions of astrocytes on carbon nanofiber materials. Biomaterials 25, 1309-1317(2004).
6. Ellis-Behnke RG, Liang YX, You SW et al.: Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc. Natl Acad. Sci. USA 103, 5054-5059(2006).
7. Neuwelt EA, Varallyay P, Bago AG et al.: Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol. Appl. NeurobioL 30, 456-471 (2004).
8. Jain KK: Personalized neurology. Personalized Med. 2, 15-21 (2005).